Founded in 2022, MoleculeMind operates at the intersection of artificial intelligence, biology, and engineering. Our multidisciplinary scientific team has developed pioneering technologies, including our proprietary MoleculeOS® platform, to overcome the limitations of natural proteins. By designing next-generation biologics—from therapeutic proteins to industrial enzymes—we aim to address critical global challenges in healthcare and biomanufacturing.